Register Login

Zentalis Pharmaceuticals (ZNTL)

Bruns Ingmar 🟢 acquired 365.0K shares (1 derivative) of Zentalis Pharmaceuticals, Inc. (ZNTL) at $2.84 ($1.0M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 10, 2026, 1:36 a.m.

    🔍 Bruns Ingmar (Executive)

    Company: Zentalis Pharmaceuticals, Inc. (ZNTL)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 365,000

    Detailed Transactions and Holdings:

    • Acquired 365,000 shares of Stock Option (Right to Buy) at $2.84 per share (Derivative)
      Date: 2026-01-08 | Code: A | Expires: 2036-01-07 | equity_swap_involved: 0 | shares_owned_after: 365,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
    • REMARKS: Exhibit 24 - Power of Attorney

Search

News categories